TNP-Ω™

TARGETED NEURAL PROTECTION (TNP-Ω) TNP is an experimental supplement “targeted” to address adverse neural and other aging-related issues (“Alzheimer’s, Parkinson’s, Type 2-diabetes etc.).   Targeting involved a process of 1) working backward step-by step from each final adverse state of interest [e.g. Alzheimer’s Disease (AD)], and 2) identifying transition blocking interventions from meta-analyses and other systematic research reviews.   With specific regard to TNP, two integrative “prongs” were identified with emerging promise for significantly slowing-blocking several layers of significant transitions Selected B Vitamins; and Phytochemical Sources.    Targeted B-vitamins – the first prong – provides neuroprotection via several interrelated avenues of action [esp., serving to reduce plasma homocysteine (tHcy) and AD associated beta-amyloid levels.]  Phytochemicals, the second prong, likewise provides protection by a spectrum of other avenues of action.    These include: antioxidant,